American Society of Hematology Guidelines for Management of Cancer-Associated Thrombosis
Introduction The risk of venous thromboembolism (VTE) is substantially increased in patients with cancer especially...
AUTHORS
Gary Lyman
Co-Director, Hutchinson Institute for Cancer Outcomes Research. Public Health Sciences and Clinical Research Divisions, Fred Hutchinson Cancer Research Center. Professor of Medicine, Public Health, and Pharmacy, University of Washington, USA
Investigating the drug−drug interactions occurring in cancer-associated thrombosis: use of checkpoint inhibitors and direct oral anticoagulants in a real-world setting
Advances in medicine and the possibility of keeping multiple diseases under control via medication have increased the...
Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer
The authors of a recent study1 have taken a novel look at the impact of venous thromboembolism (VTE) among...